• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Skye Bioscience Inc (NQ: SKYE )

    3.720 -0.240 (-6.06%)
    Streaming Delayed Price Updated: 3:34 PM EDT, Sep 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 160,570
    Open 4.050
    Bid (Size) 3.720 (9)
    Ask (Size) 3.730 (4)
    Prev. Close 3.960
    Today's Range 3.500 - 4.118
    52wk Range 2.950 - 17.65
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players
    Novo Nordisk announced positive Phase 2a trial results for monlunabant, showing significant weight loss with a 10 mg dose. However, investors reacted to limited gains at higher doses. Corbus... 
    Via Benzinga
    US Stocks Edge Lower; FedEx Earnings Miss Views
    Via Benzinga
    Topics Earnings
    Exposures Financial

    Performance

    YTD
    -70.69%
    -70.69%
    1 Month
    -40.00%
    -40.00%
    3 Month
    -48.76%
    -48.76%
    6 Month
    -70.69%
    -70.69%
    1 Year
    -70.69%
    -70.69%

    More News

    Read More
    Skye Bioscience, Inc. (SKYE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Skye Bioscience, Inc. (SKYE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    SKYE Investors Have Opportunity to Join Skye Bioscience, Inc. Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    Beacon Biosignals Announces Strategic Collaboration with Skye Bioscience to Integrate Sleep Quality and Sleep Apnea Endpoints in CBEYOND™ Phase 2 Trial of Nimacimab for Obesity
    From Beacon Biosignals
    Via GlobeNewswire
    3 Biotech Stocks That Can Gain Exponentially By Leveraging AI
    Via Talk Markets
    Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Skye Bioscience Pivots To Obesity After Glaucoma Flop; Shares Plummet
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Perion Network Cuts Revenue Outlook, Joins Skye Bioscience And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?
    Via InvestorPlace
    Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.